Source: Virtual Congress 2020 – Occupational exposure as a cause of respiratory disease
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
L. Shpagina (Novosibirsk, Russian Federation), M. Zenkova (Novosibirsk, Russian Federation), A. Saprykin (Novosibirsk, Russian Federation), I. Shpagin (Novosibirsk, Russian Federation), O. Kotova (Novosibirsk, Russian Federation), E. Logashenko (Novosibirsk, Russian Federation), A. Tsygankova (Novosibirsk, Russian Federation), G. Kuznetsova (Novosibirsk, Russian Federation), N. Kamneva (Novosibirsk, Russian Federation), E. Anikina (Novosibirsk, Russian Federation), D. Gerasimenko (Novosibirsk, Russian Federation). Monocyte subpopulations, airway inflammation and lung function in patients with occupational chronic obstructive pulmonary disease from exposure to industrial aerosols containing nanoparticles. 647

Member's Comments

No comment yet.

Related content which might interest you: Exacerbations of occupational chronic obstructive pulmonary disease due to industrial aerosols containing nanoparticles after recovering from COVID-19 Source: Virtual Congress 2021 – Occupational COVID-19 and respiratory infections Year: 2021 Revisiting the role of pulmonary surfactant in chronic inflammatory lung diseases and environmental exposure Source: Eur Respir Rev, 30 (162) 210077; 10.1183/16000617.0077-2021 Year: 2021 The impact of airborne occupational exposure in chronic obstructive pulmonary disease Source: Annual Congress 2010 - The impact of airborne occupational exposure in COPD Year: 2010 Airway inflammation in COPD: physiological outcome measures and induced sputum Source: Eur Respir J 2003; 21: 19S-28S Year: 2003 Urban air pollution and chronic obstructive pulmonary disease: a review Source: Eur Respir J 2001; 17: 1024-1033 Year: 2001 Effect of 3-week pulmonary rehabilitation on airway inflammation in patients with chronic obstructive lung diseases Source: Annual Congress 2007 - Current issues in airway physiology, pharmacology and monitoring Year: 2007 Mechanism of lung injury caused by PM10 and ultrafine particles with special reference to COPD Source: Eur Respir J 2003; 21: 47S-51S Year: 2003 Variability and effects of bronchial colonization on symptoms and lung function in moderate COPD Source: Annual Congress 2006 - Clinical aspects and treatment of lower respiratory infection in COPD patients Year: 2006 Evidence of mast-cell activation in a subset of patients with eosinophilic chronic obstructive pulmonary disease Source: Eur Respir J 2002; 20: 325-331 Year: 2002 Variability of bronchial inflammation in chronic obstructive pulmonary disease: implications for study design Source: Eur Respir J 2006; 27: 293-299 Year: 2006 Therapeutic saline inhalation: effects on lung function and dyspnoea in patients with chronic obstructive airway diseases Source: Eur Respir J 2001; 18: Suppl. 33, 484s Year: 2001 Bacterial load in chronic obstructive pulmonary disease and its relationship with airway inflammation and lung function Source: Annual Congress 2011 - Role of infection in exacerbations of COPD Year: 2011 Cigarette smoke induced pulmonary emphysema is attenuated in CCR6 deficient mice Source: Annual Congress 2006 - Cell biology of asthma and COPD Year: 2006 The role of biomarkers to identify bacterial and eosinophilic airway inflammation in exacerbations of chronic obstructive pulmonary disease Source: Annual Congress 2010 - Induced sputum in relation: a fresh look on phenotyping and monitoring Year: 2010 Assessment of inhalation technique in patients with bronchial asthma and chronic obstructive pulmonary disease Source: Virtual Congress 2020 – Asthma inhalers: devices and adherence studies Year: 2020 Lung function and sputum neutrophil changes in an experimental model of virus-induced COPD exacerbations Source: Annual Congress 2005 - COPD: role of infection Year: 2005 The role of inflammation in prevalence of chronic obstructive pulmonary diseases in wood workers Source: Eur Respir J 2007; 30: Suppl. 51, 599s Year: 2007 Accumulation of dendritic cells in small airways of patients with chronic obstructive pulmonary disease Source: Annual Congress 2007 - COPD, sarcoidosis, idiopathic pulmonary fibrosis, cystic fibrosis, gastro-oesophageal reflux and cough variant asthma - pathogenesis and differential diagnosis Year: 2007 Patients with idiopathic pulmonary fibrosis and chronic obstructive lung disease leak inhaled nanoparticles to the blood. Source: International Congress 2019 – Involvement of the environment and inflammation in pulmonary remodelling Year: 2019 Airway epithelial inflammatory responses and clinical parameters in COPD Source: Eur Respir J 2003; 22: 94-99 Year: 2003